Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah Kinvig

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Clinical Pharmacology|January 6, 2022
Drug-Drug Interactions in People Living With HIV at Risk of Hepatic and Renal Impairment: Current Status and Future PerspectivesNicolas Cottura, Hannah Kinvig, Sandra Grañana-Castillo, et al.
Expert Review of Gastroenterology & Hepatology|November 2, 2017
The biological challenges and pharmacological opportunities of orally administered nanomedicine deliveryDarren Michael Moss, Paul Curley, Hannah Kinvig, et al.
HIV Medicine|July 30, 2021
In vitro assessment of the potential for dolutegravir to affect hepatic clearance of levonorgestrelOwain Roberts, Hannah Kinvig, Andrew Owen, et al.
Clinical Pharmacokinetics|August 22, 2018
Repository Describing an Aging Population to Inform Physiologically Based Pharmacokinetic Models Considering Anatomical, Physiological, and Biological Age-Dependent ChangesFelix Stader, Marco Siccardi, Manuel Battegay, et al.
Clinical Pharmacokinetics|October 5, 2019
Physiologically Based Pharmacokinetic Modelling to Identify Pharmacokinetic Parameters Driving Drug Exposure Changes in the ElderlyFelix Stader, Hannah Kinvig, Melissa A Penny, et al.
European Journal of Drug Metabolism and Pharmacokinetics|September 30, 2022
Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic ModellingHannah Kinvig, Nicolas Cottura, Andrew Lloyd, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2018
Analysis of Clinical Drug-Drug Interaction Data To Predict Magnitudes of Uncharacterized Interactions between Antiretroviral Drugs and ComedicationsFelix Stader, Hannah Kinvig, Manuel Battegay, et al.
Pharmaceutical Research|February 14, 2023
Integrating Forward and Reverse Translation in PBPK Modeling to Predict Food Effect on Oral Absorption of Weakly Basic DrugsYesenia L Franco, Lais Da Silva, Nitin Charbe, et al.
British Journal of Clinical Pharmacology|May 30, 2020
Effect of ageing on antiretroviral drug pharmacokinetics using clinical data combined with modelling and simulationFelix Stader, Perrine Courlet, Hannah Kinvig, et al.
Clinical Pharmacology and Therapeutics|August 11, 2020
Clinical Data Combined With Modeling and Simulation Indicate Unchanged Drug-Drug Interaction Magnitudes in the ElderlyFelix Stader, Perrine Courlet, Hannah Kinvig, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Clinical Pharmacology|January 6, 2022
Drug-Drug Interactions in People Living With HIV at Risk of Hepatic and Renal Impairment: Current Status and Future PerspectivesNicolas Cottura, Hannah Kinvig, Sandra Grañana-Castillo, et al.
Expert Review of Gastroenterology & Hepatology|November 2, 2017
The biological challenges and pharmacological opportunities of orally administered nanomedicine deliveryDarren Michael Moss, Paul Curley, Hannah Kinvig, et al.
HIV Medicine|July 30, 2021
In vitro assessment of the potential for dolutegravir to affect hepatic clearance of levonorgestrelOwain Roberts, Hannah Kinvig, Andrew Owen, et al.
Clinical Pharmacokinetics|August 22, 2018
Repository Describing an Aging Population to Inform Physiologically Based Pharmacokinetic Models Considering Anatomical, Physiological, and Biological Age-Dependent ChangesFelix Stader, Marco Siccardi, Manuel Battegay, et al.
Clinical Pharmacokinetics|October 5, 2019
Physiologically Based Pharmacokinetic Modelling to Identify Pharmacokinetic Parameters Driving Drug Exposure Changes in the ElderlyFelix Stader, Hannah Kinvig, Melissa A Penny, et al.
European Journal of Drug Metabolism and Pharmacokinetics|September 30, 2022
Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic ModellingHannah Kinvig, Nicolas Cottura, Andrew Lloyd, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2018
Analysis of Clinical Drug-Drug Interaction Data To Predict Magnitudes of Uncharacterized Interactions between Antiretroviral Drugs and ComedicationsFelix Stader, Hannah Kinvig, Manuel Battegay, et al.
Pharmaceutical Research|February 14, 2023
Integrating Forward and Reverse Translation in PBPK Modeling to Predict Food Effect on Oral Absorption of Weakly Basic DrugsYesenia L Franco, Lais Da Silva, Nitin Charbe, et al.
British Journal of Clinical Pharmacology|May 30, 2020
Effect of ageing on antiretroviral drug pharmacokinetics using clinical data combined with modelling and simulationFelix Stader, Perrine Courlet, Hannah Kinvig, et al.
Clinical Pharmacology and Therapeutics|August 11, 2020
Clinical Data Combined With Modeling and Simulation Indicate Unchanged Drug-Drug Interaction Magnitudes in the ElderlyFelix Stader, Perrine Courlet, Hannah Kinvig, et al.
Pageof 2